Residual Neuromuscular Blockade in the Critical Care Setting is organized by American Association of Critical - Care Nurses (AACN) and will be held during Mar 01, 2018 - Mar 01, 2021.
The American Association of Critical-Care Nurses (AACN) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s (ANCC's) Commission on Accreditation, ANCC Provider Number 0012 (60 min contact hour). AACN has been approved as a provider of continuing education in nursing by the California State Board of Nursing, California Provider number CEP01036 for 1.2 contact hours (50 min contact hour).
Activity Summary :
The article includes a review of the current uses for the neuromuscular blockade, pathophysiology of the neuromuscular junction, pharmacologic characteristics of neuromuscular blocking agents (including drug-drug interactions), monitoring modalities, and effectiveness of reversal agents. Treatment recommendations pertinent to residual neuromuscular blockade are outlined.
• Facilitate the safe recovery of patients undergoing general anesthesia.
• Identify early signs of deterioration, complications, and patient risk factors associated with residual paralysis.
• Evaluate treatment interventions for those patients with evidence of residual neuromuscular blockade.
Additional details will be posted as soon as they are available.
Clinical Pharmacology, Critical Care Medicine, Nurse anesthesia